IVAN JAVIER
NUÑEZ GIL
PROFESOR
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitari de Bellvitge (43)
2024
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Non-atherosclerotic acute cardiac syndromes: spontaneous coronary artery dissection and Takotsubo syndrome. Comparison of long-term clinical outcomes
Coronary artery disease, Vol. 35, Núm. 1, pp. 50-58
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine, Vol. 124, pp. 108-114
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study
Thrombosis Journal, Vol. 21, Núm. 1
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Diabetes Research and Clinical Practice, Vol. 203
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
2022
-
Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
Journal of Clinical Medicine, Vol. 11, Núm. 11
-
Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
PLoS ONE, Vol. 17, Núm. 2 February
-
Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 6
-
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2021
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Serum metabolomic analysis suggests impairment of myocardial energy production in takotsubo syndrome
Metabolites, Vol. 11, Núm. 7
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182